GENDER MATTERS IN TREATMENT DEMAND Isidore S. Obot, Ph.D., M.P.H. Department of Mental Health and Substance Abuse World Health organization Geneva, Switzerland.

Slides:



Advertisements
Similar presentations
Programme: 145 sessions & social events
Advertisements

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
GLOBAL DIMENSION AND BURDEN OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE Isidore S. Obot, PhD, MPH. Department of Mental Health and Substance Abuse World.
Slide 1 Welcome Address Regulating Authorities E&P Service Industry E&P Operators.
TB and HIV: Tightly Linked… and Why We Should Care.
The Freedom to Publish Opinion Poll Results June 15, 2012 Presented by Dr. Robert Chung Director of Public Opinion Programme, The University of Hong Kong.
The management of outpatients with stable coronary artery disease in clinical practice.
Pension Reform and Labor Market Policies In Central Europe Elaine Fultz Senior Specialist in Social Security International Labor Organization Budapest.
The Political Geography of AIDS
Final Project Presentation Guidelines Each group has 12 minutes MAX PowerPoint available for use –Save presentation to Group Web Page and bring CD- rom.
ALCOHOL, GENDER, AND CULTURE: Why are they important for policy? Sharon C. Wilsnack, Ph.D. University of North Dakota School of Medicine & Health Sciences.
FROM GLOBAL TO LOCAL: AN INTRODUCTION TO THE SYMPOSIUM David Jernigan, PhD Johns Hopkins Bloomberg School of Public Health.
Nathalie Moreau Anne Hublet Alcohol use in year olds in Belgium. Results from the Health Behaviour in School-aged Children.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
UNODC response to HIVAIDS Baltic Forum "Drug Control in the Baltic Region: New Challenges" September 2005 Vilnius Zhannat Kosmukhamedova, HIV/AIDS.
Assessing child-well-being: perspectives and experiences of Health Behaviour in School- Aged Children (HBSC) Study A World Health Organization Cross- National.
.. Alcohol and Public Health in the Americas Maristela G. Monteiro, M.D., Ph.D. Senior Advisor on Alcohol and Substance Abuse.
Overview of Mental Health Worldwide Pamela Smith, MD Fall
Health Promotion Networks. Copenhagen, Denmark. 16 October The Health in Prisons Programme HIPP – WHO/Europe’s Network on Prison & Health Stefan.
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
Area Definition III KAM,Bratislava. The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
Annual report 2010: the state of the drugs problem in Europe.
ELSA Law Schools ICM Cluj-Napoca, 21st April 2015.
PSYCHOACTIVE SUBSTANCES AND THE WAYS OF AVOIDING BAD HABITS.
How Big is the Alcohol Problem Locally? Jess Mookherjee Consultant in Public Health Kent.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: December 2014.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Volume of alcohol consumption, patterns of drinking and burden of disease in the Americas 2002 Jürgen Rehm 1,2,3 & Benjamin Taylor 2 1 Institut für Suchtforschung.
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
"Protecting the Unborn Child" European Parliament Policy Debate 7 th September 2011, Brussels Measuring the problem of alcohol and the unborn child Dr.
KAM Prague 3 rd -7 th September AA Workshop Studies Abroad Projects Embrace cultural diversity!
Conference Objectives To highlight the rising number of people living with HIV in Europe who are unaware of their serostatus To identify political, structural,
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Pusan National University Local Committee
ICM Bodrum 24 th October AA Workshop Legal Research Group.
NextLastEurope. NextLastEurope  The region of Europe is the area on the map shaded dark purple. Europe.
PAGE 1 Russia as a Market of Elderly Tourism - Needs, Challenges, Potential.
2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.
HIV vulnerabilities of sex workers in Europe
Enrollment Update 1 September 2015 Department of Mental Health and Substance Abuse Global Clinical Practice Network for Field Studies of ICD-11 Mental.
European Federation of Public Service Unions (EPSU)
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
WOMEN PROFILE AND GENDER ANALYSIS IN TREATMENT DATA UNODC DATA.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
Health Statistics and Informatics Non-communicable diseases A global overview.
The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
Health in Prisons Project Sixth Meeting Prison Health Expert Group Oslo, Norway 30 September – 1 October 2008 Brenda van den Bergh World Health Organization.
Hyeon Jung Lee (Anthropology, SNU). How can we understand East Asian societies and cultures, particularly the aspects of modernity, through the lens of.
EXPOSURE TO TOBACCO SMOKE IN THE EUROPEAN UNION 2nd Working Meeting on Adult Premature Mortality in the European Union October 2006, Warsaw, Poland.
Liver cirrhosis mortality in European countries II Working Meeting on Adult Premature Mortality in European Union Warsaw, October 2006.
Protecting the unborn baby from alcohol European Parliament, 17 September 2013 Dr Lars Møller Programme Manager World Health Organization Regional Office.
World Health Organization Regional Office for Europe
Contents - HIV global slides
10th Annual Susan Li Conference
DISTRIBUTION AUTOMATIC - GENERATION
Comparative European Law on Abortion Joint Oireachtas Committee on the Eighth Amendment of the Constitution – 8 November 2017 Leah Hoctor, Regional.
WHO minimum public health data set on prison health
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Freya Vander Laenen STRUCTURED SESSION Costs of drug treatment
People who inject drugs
HIV/AIDS Surveillance in Europe 2011
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
Jürgen Rehm 1,2,3 & Benjamin Taylor 2
Contents - HIV global slides
NDPHS EXPERT GROUP ON ALCOHOL AND SUBSTANCE ABUSE (ASA EG)
Annual Epidemiological Report for 2017 Sexually Transmitted Diseases - chlamydia - gonorrhoea - lymphogranuloma venereum - (congenital) syphilis.
Presentation transcript:

GENDER MATTERS IN TREATMENT DEMAND Isidore S. Obot, Ph.D., M.P.H. Department of Mental Health and Substance Abuse World Health organization Geneva, Switzerland

1.3 billion smokers 2 billion alcohol users 200 million illicit drug users Tobacco Alcohol Illicit Drugs Source: UNODC, 2003 Source: WHO, 2002 Global Extent of Psychoactive Substance Use 70 million with alcohol use disorders 15 million with drug use disorders

World Disease burden (DALYs) in 2000 attributable to Addictive Substances related Risks Number of Disability-Adjusted Life Years (000s)

The GENACIS Project Gender, Alcohol and Culture: An International Study – More than 30 countries involved – Sponsored by the EU, NIH, WHO,etc. – Similar instrument in LDCs – Central data management – Data collection completed

Types of data collected Demographics Work experiences Social networks Drinking behaviour Familial and other drinking contexts Drinking consequences Intimate relations and sexuality Violence and victimization Health and lifestyle (e.g., use of other substances)

CountryMenWomen Germany Italy France Finland Norway Sri Lanka Nigeria Argentina Uganda Drinking status by men and women in selected countries (%) Source: GENACIS, 2004

CountryMenWomen Germany Mexico Finland Norway Sri Lanka Nigeria Argentina Uganda Heavy episodic drinking by men and women (%) Source: GENACIS, 2004

CountryMenWomen Germany Belgium France Finland Japan Mexico Brazil Argentina Poland Prevalence of alcohol dependence Source: Global Alcohol Database, 2004

THE ATLAS-SU PROJECT

Data domains No. of males and females in Tx for alcohol and drug problems Injecting drug use Drug law and policy Treatment service administration Types of services Financing treatment Human resources Treatment data system Prevention services

WHO region No. of member states No. of responding countries % response AFR (Africa) AMR (Americas) EMR (E. Mediterranean) EUR (Europe) SEAR (S. East Asia) WPR (W. Pacific) Total Number of member states in each WHO region and survey response rates (%)

CountryMalesFemales Barbados Bolivia Brazil Costa Rica Ecuador Guatemala Guyana Nicaragua Peru % of male and female clients in treatment for alcohol problems in the Americas

CountryMalesFemales Barbados Bolivia Brazil Costa Rica Ecuador Guatemala Guyana Nicaragua Peru % of male and female clients in treatment for drug problems in the Americas

Availability of treatment data reporting system Overall, 72% and at least 50% of the countries in each region (except AFR) reported the existence of a treatment data system. Treatment data covered in the reporting system included: total number of admissions, types of drugs used by clients, mortality, IDU and HIV/AIDS data, and completion rates. However, data included in the systems did not seem to be easily accessible.

PERCENTAGES OF COUNTRIES REPORTING "HIGH LEVEL" OF AVAILABILITY OF SELECTED TREATMENT MODALITIES Source: WHO Atlas-SU project

Other relevant findings Few countries reported the existence of harm reduction programmes. For example, needle exchange programmes existed in only 28 of the countries with the highest proportions of countries in Europe and Southeast Asia. Psychiatric and general hospitals were the most usual place where people went for treatment for substance use problems.

WHO's CEE Pharmacotherapy of Opioid DependenceProject 15 countries – Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Kyrgyz Republic, Latvia, Lithuania, Poland, Russian Federation, Slovak Republic, Slovenia, Ukraine

CEE Project: Documentation of Tx Data Client/patient data – Entry data: demographic, family history, personal history, social network, substance use, past tx experiences, convictions, legal status – Data at discharge: Type of discharge, follow-up tx, changes from entry data Service description – Structural: legal basis, funding, programme, target population – Annual: staff turnover, conceptual changes Tx description: diagnostic assessment, tx plan, medical care, etc.

Gender and Tx Demand in Bulgaria 79% M and 21% F in 2000 (stable over the past 5-6 years) In MM Tx as 31 December: 58 F & 143 M Mean age – 29 F & 31 M Youngest patient in MM: 19F, 20M Oldest patient: 48F, 57M

Lithuania Males account for 75% of opioid users entering tx. Overdose deaths – 1998: Males - 23, Females - 9 – 1999: Males - 30, Females - 7

Russian Federation In 2000, 286,630 opioid dependent patients treated 15.3% were female

Gender and Substance Use/Dependence Women are less likely than men to drink or use illicit drugs but the gaps are closing in many countries, especially among the young. The gap is least with heavy episodic or binge drinking, a pattern of drinking associated with increased physical, social and psychological problems requiring treatment. Access to treatment is a problem in all parts of the world, influenced by availability and price. There are many internal and external barriers to help seeking and care among women with alcohol and other drug problems (e.g. shame, fear of losing custody of children, service availability, etc.) Primary care is an ideal opportunity for the identification and management of alcohol and other drug problems. Reliable estimates of substance use and treatment data are essential for planning and service delivery in every country of the world.